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ABSTRACT
Introduction The COVID-19 pandemic resulted in a 
national lockdown in India from midnight on 25 March 
2020, with conditional relaxation by phases and zones 
from 20 April. We evaluated the impact of the lockdown 
in terms of healthcare provisions, physical health, mental 
health and social well- being within a multicentre cross- 
sectional study in India.
Methods The SMART India study is an ongoing house- to- 
house survey conducted across 20 regions including 11 
states and 1 union territory in India to study diabetes and 
its complications in the community. During the lockdown, 
we developed an online questionnaire and delivered it in 
English and seven popular Indian languages (Hindi, Tamil, 
Marathi, Telegu, Kannada, Bengali, Malayalam) to random 
samples of SMART- India participants in two rounds from 5 
May 2020 to 24 May 2020. We used multivariable logistic 
regression to evaluate the overall impact on health and 
healthcare provision in phases 3 and 4 of lockdown in red 
and non- red zones and their interactions.
Results A total of 2003 participants completed this 
multicentre survey. The bivariate relationships between 
the outcomes and lockdown showed significant negative 
associations. In the multivariable analyses, the interactions 
between the red zones and lockdown showed that all 
five dimensions of healthcare provision were negatively 
affected (non- affordability: OR 1.917 (95% CI 1.126 to 
3.264), non- accessibility: OR 2.458 (95% CI 1.549 to 
3.902), inadequacy: OR 3.015 (95% CI 1.616 to 5.625), 
inappropriateness: OR 2.225 (95% CI 1.200 to 4.126) and 
discontinuity of care: OR 6.756 (95% CI 3.79 to 12.042)) 
and associated depression and social loneliness.
Conclusion The impact of COVID-19 pandemic and 
lockdown on health and healthcare was negative. The 
exaggeration of income inequality during lockdown can 
be expected to extend the negative impacts beyond the 
lockdown.
INTRODUCTION
Social distancing is a successful mitigation 
strategy used to slow transmission rates 
during communicable disease outbreaks.1 
Unlike other virus epidemics, COVID-19, 
caused by SARS- CoV-2, rapidly evolved into a 
pandemic and it was declared a global health 
emergency by WHO on 30 January 2020.2 
Preventive strategies to mitigate the mortality 
rates due to this virus have been challenging 
even in many high- income countries with low 
population density.3
The government of India declared a 
nationwide lockdown from 25 March 2020 as 
a preventative measure against the COVID-19 
pandemic in India when the numbers of 
recorded cases were only 519, with nine 
reported deaths.4 Although there was signif-
icant scepticism about this world’s largest 
lockdown, maintaining social distancing in 
India is a mammoth challenge. Living condi-
tions vary widely in India, population density 
range from an average of 1202–54 000 people 
per square mile in cities such as Mumbai, 
and India is home to 17% of the global 
population. Given the risks that India faced 
if COVID-19 affected the nation at the pace 
that it affected Italy and other countries, the 
government of India had to rapidly respond 
with such a strategic decision.
Strength and limitations of this study
 ► This multicentre study highlights the impact of the 
lockdown on healthcare services and general, social 
and mental health of the population.
 ► We were able to study the impact based on the se-
verity of lockdown by comparing phases 3 and 4 
of the lockdown and also differences on impact in 
red and non- red zones and influence of lockdown in 
people with diabetes.
 ► The interactions between the pandemic and lock-
down have resulted in both positive and negative 
impacts.
 ► As this is a cross- sectional study and data were not 
collected prior to lockdown, we are unable to infer 
causality.
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As population movement from outside and within India 
maintained the rise of cases,5 the lockdown had to be 
extended further on three occasions, referred to as lock-
down phases 1 –4 and conditional relaxation of the lock-
down is still ongoing. As there were regional differences 
in COVID-19 cases, the 739 districts in India (average 
population 1.7×106 but can range from 57×103 to 4 x 106) 
were also divided into zones colour coded as red, orange 
and green during phases 2–4 based on the doubling rates, 
with the red zone representing the highest doubling rates.
There was global press coverage on this lockdown 
related disruption, chaos, financial difficulties, lack of 
shelter and food for the vulnerable populations, fear, 
social exclusion, stigma and misinformation on COVID-
19. However, there is a lack of evidence of the impact of 
this lockdown on the health of individuals at population 
level.
Given that 70% of the healthcare in India is provided 
by the private sector and most only provided minimal 
services during the lockdown, we hypothesised that the 
immediate consequences of lockdown would be restricted 
healthcare provisions and negative impact on the general 
health, mental health and social well- being of the popu-
lation.6 Reduced capacity due to social distancing and 
other restrictions after relaxation may also be a cause of 
interruptions to healthcare provision.
We report here the results of a questionnaire- based 
survey designed to study the impact on healthcare provi-
sions and general, social and mental health of individ-
uals that participated in a multicentre study (SMART 
India).7 Our research question was ‘Will the severity of 
the pandemic and restrictiveness of lockdown stage affect 
the access to healthcare and the health and well- being of 
the participants in the SMART India study?’
METHODS
All participants gave verbal informed consent before data 
collection for this survey.
Smart India study
The SMART India study, funded by the Global Challenge 
Research Fund and UK Research & Innovation (UKRI), is 
a household survey on diabetes and its complications. The 
aim of the SMART India study is to develop practical and 
affordable models to (1) diagnose people with diabetes 
and pre- diabetes and (2) identify those at risk of diabetes 
complications so that these models can be applied to the 
population in low- income and middle- income countries 
(LMIC) where laboratory tests are unaffordable.7
The study sample was based on a multistage, stratified 
sampling technique using data from the 2011 census of 
India and covered different geographical regions (North, 
South, East and West) and included 11 states and 1 union 
territory: Assam, Chhattisgarh, Karnataka, Kerala, Madhya 
Pradesh, Uttar Pradesh, Maharashtra, Odisha, Tamil 
Nadu, Telangana, West Bengal and Delhi. All survey clus-
ters were independent samples. Each region had three 
clusters stratified into urban, rural and a pre- defined 
special category of population such as people with poor 
access to healthcare, or cohorts that are presumed high 
risk or low risk of developing diabetes. Each cluster will 
screen 800–2000 consenting participants 40 years or older 
for a cumulative sample size of a minimum of 48 000.
In each region, a census enumeration block that usually 
consists of 125–150 households with a population of 
650–700 was the primary sampling unit for urban areas 
while villages were defined in the rural areas. Bigger 
villages were further divided to ensure that approximately 
300 households could be covered. The house- to- house 
survey was conducted by approaching each household in 
consecutive streets in each area.
The inclusion criteria are adults who are ≥40 years of age 
(special groups may contain adult population of any age) 
who are local residents of Indian origin and are willing 
to give informed consent. Exclusion criteria include 
vulnerable adults in whom it may not be possible to carry 
out all the tests; pregnant and breast feeding women; 
anyone in the opinion of the fields worker deemed too 
ill to be screened; and those who are currently partici-
pating in intervention trials with investigational medic-
inal products.
In the SMART India study, diabetes was defined as 
known diabetes on anti- diabetes medications or diet 
controlled or a random blood sugar of >200 mg/mL 
(8.9 mmol/mmol).
Participants for the COVID-19 questionnaire study
Two random samples in phases 3 and 4 of the lockdown 
were obtained from participants of the ongoing SMART 
India study.8 First sample was a random sample of the 
whole SMART India cohort and second random sample 
included people with diabetes from the study cohort to 
ensure we had a good proportion of the sample consisting 
of people who would need to access healthcare. We anal-
ysed both samples together because of the low cell counts 
when adjusting for the complex design relatively large 
numbers of variables. Weighting was used to ensure the 
age and gender distribution of our samples were similar 
to that of the latest census of India.
Severity of lockdown in India and description of zones
The lockdown in India was divided into phases. During 
phase 1 of the lockdown, people were urged to stay 
indoors, all services, except healthcare and other essen-
tial services, were closed, non- essential transport was 
suspended and most activities were prohibited. In phase 
2, the country was divided into three zones: red, orange 
and green based on the number of cases of COVID-19 
and spread of the virus. In red zones, all forms of public 
transport, for example, by air, rail, road were suspended, 
most institutions were closed, and gatherings of people 
for any purpose was prohibited. Only emergency services 
and those related to healthcare were allowed. In orange 
zones, outpatient departments and clinics were allowed 
to be open with social distancing norms and other 







pen: first published as 10.1136/bm




3Raman R, et al. BMJ Open 2021;11:e043590. doi:10.1136/bmjopen-2020-043590
Open access
safety precautions. Limited movements of taxis and cab- 
aggregators were allowed, and interdistrict movement 
of people for permitted activities was allowed. In the 
green zones, most restrictions were removed in a phased 
manner.
In phase 3, the red zone districts continued to remain 
under lockdown. The orange zone districts had no 
public transportation but private and hired vehicles were 
permitted and green zone districts operated with buses 
limited to 50% capacity. In phase 4, the states were given 
more power in the implementation of lockdown and 
delineation of the zones. Our COVID-19 lockdown study 
was conducted during phases 3 and 4 of the lockdown.
Four lockdown stages can be described in the order of 
strictness of lockdown from the least to the most: phase 
3 lockdown—non- red zones, phase 3 lockdown—red 
zones, phase 4 lockdown—non- red zones and phase 4 
lockdown—red zones.
Questionnaire
The questionnaire was designed to evaluate provision of 
healthcare services and self- rated impact of COVID-19 
lockdown on physical, mental and social well- being and 
was developed from existing validated instruments from 
Europe. It was translated to seven different languages 
to address non- English- speaking population. Accuracy 
of the translations was checked by three health profes-
sionals per language. Prior to the survey being carried 
out a test- run was done on 14 participants, who were 
not part of the SMART- India study, to cross- validate the 
questionnaire. The fieldworkers from the 20 centres in 
the SMART India study were trained to administer the 
questionnaire by telephone and the data were entered 
into an electronic cloud- based database, developed 
specifically for the SMART India study. The data manage-
ment group consisted of two project coordinators and 
an IT expert. A checklist was prepared and weekly web 
meetings conducted with the interviewers. In each call, 
two interview forms were randomly picked and checked 
for accuracies. The data management group monitored, 
checked and verified the data entry before the database 
was locked for analysis.
Outcome variables
The outcomes were the five dimensions of healthcare 
provision viz. availability, affordability, accessibility, 
appropriateness, and adequacy, patient experience and 
continuity of care and measures of self- reported physical 
health, depression, emotional and/or social loneliness. 
For this analysis, we derived binary variables describing 
poor or negative outcomes using a subset of questions.
Dimensions of healthcare provision
We measured three aspects of healthcare services, that is, 
access, patient experience and continuity of care. Access 
was defined as ‘a general concept that summarises a set 
of more specific dimensions describing the fit between 
the patient and the healthcare system.’9 Five inter- related 
but distinct dimensions, 5 ‘A’s, were defined for access: 
adequate, accessible, affordable, appropriate and avail-
able.10 We adapted questions from a patient- led survey 
developed by European Patients Forum to measure 
access.11
Availability of healthcare was measured using a ques-
tion about ease of obtaining overall access and scored 1 
if accessing information was not easy. Affordability was 
measured by asking whether the participant experienced 
financial difficulties due to spending on healthcare during 
the lockdown (1=sometimes or often). Accessibility of 
healthcare was measured by counting the number of 
times there was delay in getting services and dichotomised 
as none vs one or more. Similarly, adequacy of health-
care was measured by three statements on provision of 
information on treatment options, adapting treatment to 
changing needs and involvement in the treatment deci-
sions. We scored 1 if the response to any of the questions 
was ‘No’. Finally, appropriateness was measured using a 
question on whether the participant was treated for their 
medical condition differently to that they received prior 
to COVID-19 (1=treated differently).
We then measured the patient experience of health-
care during this time, which we measured by adapting 
the communication section of a questionnaire devel-
oped for LMIC.12 We asked five questions on whether 
on approaching healthcare providers, the participants 
were treated with courtesy and respect, were listened to 
and received understandable information. We scored 
one if the response to any of these questions was ‘false’. 
Lastly, we assessed whether the quality of care patients 
received during the lockdown is a break in the continuity 
of care. We used the concept of ‘experienced continuity 
of care’13 and measured it using four questions based on 
four dimensions, longitudinal, relational, flexible and 
cross- boundary.14 The binary variable was scored 1 if the 
response to any of these questions was ‘No’.
Measures of self-reported health impacts of COVID-19
The impact of the lockdown on individuals was measured 
on physical health, mental health and social well- being. 
Physical health was measured using a single- item compara-
tive self- rating question asking the participants ‘compared 
with before the lock down, how is your health in general?’ 
with a 5- point Likert scale response ranging from ‘very 
good’ to ‘very poor’ and dichotomised as poor heath for 
responses fair to very poor vs good and very good. Mental 
health was measured using the WHO-5 well- being index.15 
The responses were noted on a 6- point Likert scale scored 
0 (‘at no time’) to 5 (‘all of the time’) with the scores 
converted to a percentage scale. We dichotomised the 
score at the cut- off <51 to create a binary variable labelled 
‘Screening diagnosis of depression’.
To measure loneliness, we used the short De Jong 
Gierveld Loneliness scale16 consisting of six Likert scale 
items with five levels: ‘none of the times’, ‘rarely’, ‘some-
times’, ‘often’ and ‘all of the time’. Three of these items 
measured emotional loneliness referring to a sense of 
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emptiness, missing people around oneself and a feeling 
of rejection. The other three items referred to social 
loneliness referring to a lack of boarder engagement 
with social networks. We recoded the three items of social 
loneliness17 so that for all items the higher score meant 
greater loneliness. The scale was further dichotomised so 
that ‘none of the times’ and ‘rarely’ counted as zero and 
the rest as one. The two sub scales ranged from 0 to 3 
and the total loneliness score ranged from 0 to 6. The 
subscales were summed only if all items were non- missing 
while in computing the total score at most one missing 
item among the six can be accommodated. The subscales 
and the total score were dichotomised at >1 to produce 




In the absence of any pre- existing data, we assumed that 
a modest 50% of the participants will access healthcare 
services and during the lockdown there will be a 10% 
reduction in the proportion participants accessing health-
care services. Based on that we computed that to identify 
that difference with 80% power and at a 0.05 significance 
level, we will need 609 participants.
Analysis
The outcomes were each dimension of healthcare provi-
sion and measures of self- reported physical health, 
depression, emotional and/or social loneliness. Our 
primary exposure variables were zones of lockdown (red 
or not red) and phase of lockdown (phase 3 or phase 4). 
Control variables in the analyses included age, gender, 
rural vs urban residents, self- rated financial difficulties 
(none, some or great), occupation (working or not), 
financial situation (difficulty in meeting daily needs—
none, some or great) and living arrangements (large 
household, with spouse, alone or living with unrelated 
individuals). In analysing this data, we took into account 
the stratification in the data by multiple centres and used 
population weights by using svy commands with STATA 
(V.15). We created weights based on age and gender 
distribution of the Indian population. The target popu-
lation in our survey was between 25 and 90 years and the 
weights align our sample with the latest Indian Census 
(2011) (online supplemental table S1).
Multiple logistic regression models were used to esti-
mate the associations between outcomes and exposures. 
In all models, we included an interaction term between 
red zone and lockdown stage. Other interactions such 
as between zones, stage and presence of diabetes were 
tested but were not significant and not used in the final 
models tested. The analyses took into account stratifica-
tion by centres and population weights.
After a reviewer had suggested that our sample size 
might lack sufficient power, we estimated post hoc power 
through simulation. For this, we drew 10 000 random 
samples with replacement with the same size as our 
data and estimated the difference in proportion of the 
outcome in more strict lockdown condition (red zone in 
lockdown phase 4) and less strict conditions. Proportion 
of times the difference was not significant (at α=0.05) was 
considered as β, the probability of type II error and the 
power was then computed as 1-β. We estimated the post 
hoc power for changes in all outcomes.
Patient and public involvement statement
Patients were not allowed to visit hospitals due to lock-
down, so we assumed poor patient experiences based on 
the increased numbers of patients calling the hospitals 
for advice. Patients were not involved in the design of the 
study and were not involved in the recruitment to and 
conduct of the study. We intend to write a summary of the 
results to the participants who request for it.
RESULTS
The COVID-19 telephone survey was carried out on 
random samples of participants from the SMART India 
study cohort in two rounds, from 5 May to 24 May 2020 
during phases 3 and 4 of the lockdown respectively. The 
derivation of the random samples from the SMART India 
cohort is shown in figure 1.The survey was conducted in 
the following states/union territories: Assam, Chhattis-
garh, Karnataka, Kerala, Madhya Pradesh, Uttar Pradesh, 
Maharashtra, Odisha, Tamil Nadu, Telangana, West 
Bengal and Delhi. There was no change in zone clas-
sification between round 1 and 2 of the survey. A total 
of 2373/4325 (55%) were contactable by telephone 
and 2003/2373 (84%) consented and responded to the 
questionnaires.
The participant characteristics are shown in table 1.
Nearly 83% of the sample were aged 30–65 years, repre-
senting the population most likely be affected by the lock-
down. More than half the sample were men and nearly 
Figure 1 Flow diagram showing the derivation of the 
random samples.
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60% were working. Most of the respondents resided in 
urban areas and lived with family members. Approx-
imately 60% of the participants described having some 
form of financial difficulties. As expected, 63% of the 
participants had diabetes
Table 1 also shows the weighted proportions of these 
variables adjusted for the complex design of the survey 
in cross- tabulation with the lockdown stages and the 
results of the tests for independence. In all cases except 
for gender and working the tests were highly signifi-
cant. Therefore, in all models testing the association of 
outcomes with lockdown, these variables were entered as 
control variables.
Associations of outcome measures with lockdown
During the lockdown stages, in phase 3 and phase 4, there 
were changes in the amount of restrictions imposed with 
some relaxation in the non- red zones, and the zones were 
based on the areas of varying severity of the COVID-19 
pandemic, red zones being the worst affected. The crude 
associations between the lockdown stages and zones are 
presented in the table 2. As expected, negative outcomes 
were two to six times more likely in the more restrictive 
lockdown phase, and in areas with more severe impact 
of COVID-19. There were few exceptions. The disconti-
nuity of care was found to be significantly less likely in 
the red zones (OR 0.62 [95% CI 0.40 to 0.95]). There 
were no significant associations between non- availability 
of healthcare services and the phase of the lockdown, 
and poor health, and social loneliness with the severity of 
COVID-19 pandemic. However, when we considered the 
interaction between phases and zones, and adjusted for 
sociodemographic variables and presence of diabetes, the 
number of significant associations reduced suggesting the 
Table 1 Participant characteristics and distribution among lockdown stages












Age Weighted % in the cross- table between lockdown 
stages and control variables
  25–29 years 51 (2.5) 7.9 9 0 0
  30–65 years 1668 (83.3) 10.9 21.9 12 27.7 F(2, 4008.6) =10.534
  >65 years 284 (14.2) 1.7 2.5 2.4 4.1 p≤0.001
Gender
  Male 1098 (54.8) 7.8 19.4 7 16.5 F(1.93, 3818.53) =2.675
  Female 905 (45.2) 12.7 14 7.4 15.2 p=0.071
Working (missing=1)
  No 820 (41.0) 9.1 9.4 6.6 13.3 F(1.50, 2974.84) =2.605
  Yes 1182 (59.0) 11.4 23.9 7.8 18.5 p=0.090
Area 0 0 0 0
  Urban 1516 (75.7) 17.5 23 11.9 24.1 F(1.88, 3729.12) =4.040
  Rural 487 (24.3) 3 10.3 2.5 7.6 p=0.020
Living arrangements
  Alone 171 (8.5) 9.6 21.6 10 27.8
  With my spouse 180 (9.0) 3 6.4 1.2 1.8
  With my spouse, children 
and others
1561 (77.9) 1.1 4.7 1.3 2 F(4.08, 8090.17) =15.361
  With non- related others 91 (4.5) 6.8 0.7 1.9 0.1 p≤0.001
Financial circumstances missing=17
  No difficulties 715 (36.0) 12.8 15.4 7.9 6.4
  Some difficulties 865 (43.5) 6.5 12.3 4.9 16.3 F(2.61, 5129.13) =13.811
  Great difficulties 406 (20.4) 1.2 5.6 1.6 9.1 p≤0.001
Diabetes
  Absent 746 (37.2) 18.3 29.5 0 0 F(2.06, 4092.32) =423.311
  Present 1257 (62.8) 2.2 3.9 14.4 31.7 p<0.001
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complex nature of the relationships between our expo-
sure variables and the outcomes.
Our main exposures of interest are the lockdown stages 
and zones. In tables 3 and 4, we present the results for their 
main effects and interaction between them on healthcare 
provision and health and well- being. The main effect 
of the lockdown stage is the effect of lockdown stage 4 
and non- red zones on the outcomes; the main effect of 
red zone is the effect of red zone and lockdown stage 3 
on the outcomes; and the interaction effect is the effect 
of red zone and lockdown stage four on the outcomes. 
The main effects and interaction should be considered 
together when discussing the impact of COVID-19 lock-
down on healthcare and health.
Except for healthcare availability and negative experi-
ence, on all other healthcare outcomes, the interaction 
between the zones and stages of lockdown had significant 
negative association (Non- availability: OR 0.626 (95% 
CI 0.321 to 1.221), non- affordability: OR 1.917 (95% 
CI 1.126 to 3.264), non- accessibility: OR 2.458 (95% CI 
1.549 to 3.902), inadequacy: OR 3.015 (95% CI 1.616 to 
5.625), inappropriateness: OR 2.225 (95% CI 1.200 to 
4.126), negative patient experience: OR 0.295 (95% CI 
0.069 to 1.264) and discontinuity of care: OR 6.756 [95% 
CI 3.79 to 12.042]). This meant that in the most severe 
forms of lockdown, there was two to three times lack in 
healthcare service provision. In the earlier stage of lock-
down, there was nearly four times reduction in the avail-
ability of healthcare services and six times more negative 
patient experience.
In the case of health and well- being outcomes, the lock-
down related variables had fewer significant associations. 
The interaction between the zones and stages of lock-
down was significantly associated with depression (OR 
1.752 (95% CI 1.065 to 2.882)) and social loneliness (OR 
2.96 [95% CI 1.306 to 6.709]).
Consistently, financial difficulties predicted nega-
tive outcomes in healthcare service provision as well as 
general, psychological and social well- being. On exploring 
further, we discovered that the effect of financial difficul-
ties were considerably larger for three outcomes during 
the most severe lockdown compared with other times 
(non- accessibility: OR 11.81 (95% CI 6.24 to 22.33) vs OR 
1.82 (95% CI 1.34 to 2.46), relative difference (RD)=6.5; 
inappropriateness: OR 10.33 (95% CI 2.95 to 36.21) vs 
OR 10.33 (95% CI 2.95 to 36.21), RD=3.7; discontinuity 
of care: OR 15.22 (95% CI .58 to 30.57) vs OR 2.94 (95% 
CI 2.08 to 4.15). See online supplemental table S2 for 
other results.
Post hoc sample size power analyses using simulation 
showed that the rejection rate with our sample size alpha 
level of 0.05 was 0% for all outcomes except for non- 
availability (8.4%), negative patient experience (93.8%) 
and poor health (8.1%).
DISCUSSION
Though lockdown was introduced as an urgent national 
mitigation strategy against COVID-19, our cross- sectional 
study has shown the degree to which healthcare provision 
and health and well- being of people were affected during 
lockdown in India, especially in the red zone.
The unadjusted associations in this study showed that 
lockdown affected access to healthcare and health and 
well- being of the participants negatively. However, multi-
variable logistic regression models revealed that the nega-
tive influences of the lockdown were mainly in areas of 
high burden of the pandemic. In contrast, availability of 
healthcare, negative patient experience and poor health 
were not associated with lockdown in these models. 
Among the health outcomes, mental health and loneli-
ness were affected by the lockdown and the burden of 
pandemic while self- reported poor health had no impact. 
These results were similar to other studies from India.10 18 
Verma and Mishra6 in their survey during the first lock-
down in India reported the prevalence of moderate to 
severe depression, anxiety and stress to be 25%, 28% and 
11.6%, respectively, in the study participants.
However, the relation of the pandemic and lockdown is 
more complex. Our study supports previous reports that 
COVID-19 pandemic has resulted in some unexpected 
and sometimes beneficial outcomes due to changes in 
human behaviour and system responses.19 One such 
beneficial effect in our study was that the continuity of 
care was better in areas with greater impact of the COVID-
19. This could be the result on the focus on vulnerable 
population with pre- existing conditions. However, where 
the impact of the pandemic was higher and lockdown was 
Table 2 Associations of lockdown stage and zones with 
healthcare and health variables
  
Lockdown stages
Unadjusted OR (95% CI)
Four (ref: 3)
Zones Red (Ref: non- red)
Healthcare variables
  Non- availability 1.17 (0.79 to 1.72) 2.61 (1.49 to 4.56)
  Non- affordability 1.93 (1.44 to 2.60) 2.22 (1.47, 3.35)
  Non- accessibility 2.74 (2.03 to 3.70) 1.93 (1.26 to 2.94)
  Inadequacy 1.91 (1.42 to 2.57) 3.06 (1.97 to 4.74)
  Inappropriate 5.76 (4.29 to 7.72) 2.65 (1.81 to 3.88)
  Discontinuity of care 2.16 (1.49 to 3.12) 0.62 (0.40 to 0.95)
  Negative patient 
experience
0.75 (0.46 to 1.21) 4.91 (2.43 to 9.90)
Health and well- being
  Poor health 2.00 (1.36 to 2.94) 0.91 (0.53 to 1.57)
  WHO-5 screening for 
depression
2.61 (1.99 to 3.42) 2.99 (2.13 to 4.21)
  Emotional loneliness 1.70 (1.22 to 2.37) 4.35 (2.86 to 6.62)
  Social loneliness 2.57 (1.58 to 4.16) 1.16 (0.54 to 2.53)
  Loneliness 
(emotional and/or 
social)
1.97 (1.06 to 3.65) 3.55 (1.62 to 7.81)
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more restrictive, the healthcare outcomes were signifi-
cantly poor with the exceptions of non- availability and 
negative patient experience. We cannot offer an explana-
tion why more restrictive lockdown offered protection in 
these cases.
Several factors may account for the deteriorating 
mental health including the fear of COVID-19 infection, 
the fear of the unknown in terms of the length period of 
lockdown and the pandemic, consequences of the lock-
down on finances and well- being, continuous exposure 
to reports on COVID-19 deaths worldwide and reduced 
access to extended family, friends and other social support 
systems. It is also interesting to note that social loneliness 
increased. This may represent the inability to cope with 
the restrictions despite the availability of internet and 
smartphone technology to stay connected.
We found the income inequality to be consistent 
across all outcomes with the likelihood of poor outcomes 
increasing as financial difficulties increased. Greater finan-
cial difficulties were associated with significantly greater 
odds of non- accessibility to healthcare (twelve times), 
inappropriate health provision (eleven times) and discon-
tinuity of care (fifteen times). Greater financial stress also 
predicted poorer mental health, higher anxiety, depres-
sion and stress. It also modified the relationship between 
our main exposures and the outcomes (see online supple-
mental table S2). Historically pandemics accentuate the 
impact of socioeconomic inequalities and COVID-19 is 
no exception.20 21 As a result, the impact of the COVID-19 
pandemic will extend beyond the pandemic itself due 
to sustained and exaggerated inequalities, unless appro-
priate policy responses are made. The Government of 
India took a step in the right direction by reducing the 
financial burden on people such as an offer of optional 
moratorium on equated monthly instalments of all types 
of loans until the end of August 2020.
The need for social distancing, use of personal protec-
tion equipment, avoidance of surgery that may generate 
aerosols, testing of patients and staff and need for 
compulsory quarantine before a hospital admission have 
all caused significant constraints on the access, adequacy 
and appropriateness of healthcare services globally. 
These points were emphasised in the WHO report that 
stressed that the movement restriction measures of 
lockdown have considerable social and economic costs 
and should be implemented with the understanding, 
consent and participation of communities, and based 
on the principle of doing no harm.22 In India, Kerala’s 
Abraham Committee report on post- lockdown planning 
also cautioned that the ‘cure could be more expensive 
than the disease’ and called for a graded approach to 
tackling the epidemic.23 Legislation of telemedicine is 
an important step in tackling the restrictions imposed 
on the current face to face consultations. The board of 
governors of Medical Council of India adopted the ‘Tele-
medicine Practice Guidelines’ which includes the overar-
ching principles and practical framework of telemedicine 
for the country. In the wake of COVID-19 outbreak, it 
was amended and approved by the Ministry of Health 
and Family Welfare, Government of India officially on 
25 March 2020.24 Thus, telehealth practices are adopted 
to a variable extend in the regions where the study was 
done. Although, most healthcare providers have rapidly 
switched to telephone and video consultations to keep in 
touch with their patients, our study shows that people do 
not perceive that postlockdown treatment they receive is 
appropriate compared with prelockdown. This requires 
a significant change in perceptions of both clinical staff 
and patients on adjusting to these uncertain times.
Our study results are in keeping with a recent predic-
tive modelling on the impact of lockdown, Ghosal et 
al projected that the duration of lockdown is directly 
proportional to the worsening of glycaemic control and 
predicted an increase in diabetes- related complications 
with consequent additional load on an already over-
burdened public healthcare system.25 Another report 
indicated that the lockdown could cause weight gain 
due to poor physical activity, increased snacking and 
consumption of calorie- rich foods.26 On the contrary, 
a recent survey of people with type 2 diabetes in India 
showed better mean glycaemic control during lockdown 
compared with before lockdown.27 In our sensitivity 
analysis, we found that diabetes had no influence on the 
relationship between our outcomes and lockdown status. 
Although it as assumed that during the lockdown period, 
challenges in procuring regular prescribed medicines or 
lifestyle changes related to dietary habits, physical activity 
disruption could adversely impact people with diabetes, 
our results suggest that people with diabetes seem to cope 
with adversities of lockdown probably because they are 
already aware of available healthcare services. Indeed, the 
lockdown may have had a positive impact on some people, 
having more time to change to a healthier lifestyle.
The strengths of this study are that we were able to 
provide valuable information on the health impact 
during the COVID-19 lockdown in India. Because of 
our ongoing SMART India study, we were able to rapidly 
develop and deliver the questionnaire to participants 
who were accessible by telephone. The questionnaire 
was developed mainly from previously validated question-
naires. As far as we are aware, this is the first multicentre 
study in India conducted during the lockdown that eval-
uated the impact of the lockdown on healthcare services 
and general, social and mental health of the population. 
Our sample contained sufficient numbers of people with 
other known risk factors. About 20% of the sample were 
in the older age group. The sample also had adequate 
numbers of younger individuals to understand the impact 
in this group as recent data indicates that median age of 
COVID-19 infection in India is 38 years compared with 
the older age groups observed in the Western countries.6 
Indians are among the ethnicities that face a statistically 
higher risk of death from COVID-19 compared with those 
of white ethnicity.28 From our models, we were also able to 
report that diabetes had no influence on the relationship 
between our outcomes and lockdown status. Our post 
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hoc sample size calculation by simulation showed that the 
study had sufficient power for all the outcomes except the 
negative patient experience due to its low probability in 
the study.
Our study might be limited by its cross- sectional 
nature and use of participants of an existing study as the 
sampling frame. However, the existence of an accessible 
sample of randomly selected households across India was 
a motivating factor to undertake this study in the rapidly 
changing lockdown scenarios. Although our measures are 
from validated questionnaires, we acknowledge that these 
have never been piloted in India and so is a weakness of 
our study. Data were self- reported and not primary health 
or outcome data, the response rate was 50%, so selection 
bias (even despite weighting) might have impacted the 
results and data were not collected prior to the lockdown 
or epidemic so making firm conclusions about its affect is 
difficult. Future studies are recommended to evaluate the 
impact of economic slowdown, unemployment and finan-
cial constraints in each household with time as people’s 
responses focus on livelihood rather than lives.
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Table S1:  Comparison of Indian population and study sample after applying weights 
 Proportion of 25 to 90 year old populatipn 
Age 
group 
India (Census 2011) Survey  
25-29 16.9 16.9 
30-64 72.8 72.5 
65-90 10.3 10.6 
 
Table S2: Differential impact of financial difficulties on health care service provision and health and 
wellbeing  at different severities of lockdown 
 
Lockdown 
Outcomes Most severe Other  
OR (95%CI) OR (95%CI) 
Non-availability 4.32 (2.21, 8.43) 3.31 (2.23, 4.92) 
Non-affordability 4.06 (1.80, 9.17) 7.17 (5.06, 10.15) 
Non-accessibility 11.81 (6.24, 22.33) 1.82 (1.34, 2.46) 
Inadequacy 7.00 (3.03, 16.18) 4.48 (3.07, 6.54) 
Inappropriate 10.33 (2.95, 36.21) 3.26 (2.15, 4.94) 
Negative Patient experience 1.06 (0.12, 9.18) 6.65 (3.37, 13.14) 
Discontinuity of care 15.22 (7.58, 30.57) 2.94 (2.08, 4.15) 
Poor Health 1.29 (0.69, 2.41) 2.69 (1.91, 3.79) 
WHO-5 Screening for depression 4.69 (1.72, 12.77) 4.54 (3.31, 6.24) 
Emotional loneliness 0.77 (0.35, 1.68) 2.21 (1.52, 3.20) 
Social loneliness 2.20 (0.86, 5.64) 2.22 (1.47, 3.36) 
Loneliness emotional and/or social 4.00 (1.36, 11.73) 2.18 (1.24, 3.82) 
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